News & Events Two CTI Executives Honored at Cincinnati Business Courier C-Suite Awards

Two CTI Executives Honored at Cincinnati Business Courier C-Suite Awards

June 20, 2018

Two CTI Executives Honored at Cincinnati Business Courier C-Suite Awards

Paul Ritter, Esq.

Chief Legal Officer at CTI Clinical Trial & Consulting

Kevin Schwarz

Chief Operating Officer at CTI Clinical Trial & Consulting

 

 

 

 

 

 

 


FOR IMMEDIATE RELEASE [Covington, KY ~ June 20, 2018CTI Clinical Trial & Consulting (CTI), a multi-national, privately held, full-service contract research organization is proud to announce the recognition of two of its executive team members at the Cincinnati Business Courier's 4th annual C-Suite Awards. 

Paul Ritter is a finalist in the Chief Legal Officer category, and Kevin Schwarz is a finalist in the Chief Operating Officer category. 

The annual C-suite awards honor executives whose leadership has made a profound impact on their company. These awards will recognize CEO, CFO, COO, CMO, CLO and CTO/CIO leaders in the Greater Cincinnati community.

CTI is the only company to have two senior executives being honored at the awards.

"We are privileged to have such strong leaders on our team," remarks Tim Schroeder, CEO of CTI. "Both Paul and Kevin have played crucial roles in the growth and success of our company over the last 15 years, and we are thrilled to see this well-deserved recognition from the community."

This isn't the first time CTI has been recognized at the C-Suite awards. CTI CFO Maria Marsh won "CFO of the Year" at the awards in 2013

The 2018 awards ceremony honoring the finalists and announcing the winners will be held on Thursday, June 21 from 5:30pm-8:30pm at the Renaissance Cincinnati Hotel. Click here for more information about how to register for the event.

About CTI Clinical Trial and Consulting Services

CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in the Greater Cincinnati, OH area, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information visit www.ctifacts.com

Subscribe to our mailing list

* indicates required